Queen's discovery provides new hope for people with advanced breast cancer

January 15, 2007

KINGSTON, Ont. - A surprising discovery by Queen's University researchers that happened when their work took an unexpected turn may help women with advanced breast cancer respond better to conventional drug treatments.

The Queen's team's findings, to be published on-line today in the international journal Cancer Research, show that a newly discovered "peptide" molecule (a chain of amino acids smaller than a protein) increases the effectiveness by 350 per cent of drugs used to kill breast cancer cells.

Drs. Zongchao Jia and Vinay Singh, of the Queen's Department of Biochemistry, initially intended to study the structure of a protein called SNCG which is implicated in drug resistance in breast cancer. When unraveling the structure proved more difficult than expected, the research team looked to a similar protein associated with Alzheimer's Disease.

They were looking for "binding partners" of the Alzheimr's protein, hoping to learn how the structures of the Alzheimer protein and SNCG were held together. From this information, they were able to design a completely new peptide, which blocked SNCG's interaction with another protein, counteracting the resistance to cancer drugs. "We were excited to find that it actually can reduce anti-cancer drug resistance by three-and-a-half times," says Dr. Jia, Canada Research Chair in Structural Biology.

Noting that the peptide itself is not a drug, Dr. Jia likens it to an ingredient in the kind of "drug cocktails" used to treat HIV/AIDS. "It has to be used in combination with a drug to be effective," he says. "In the same way that cream flavors coffee to make it taste better, the peptide enhances the effectiveness of the most widely-used breast cancer drugs today."

"We greatly hope this will not only increase the positive response from patients but also will make the current drug more useful by extending its impact to a wider range of people, particularly those with a resistance problem," says Dr. Jia.

"The whole discovery 'morphed' from something entirely different. In a basic research lab like ours, this is as close as we get to treatment for a disease," says Dr. Jia, whose mother has breast cancer. "It just shows that once in a while basic science leads to discoveries that are useful in everyday life!" he adds.

Next, Dr. Jia hopes to team up with other researchers to advance the work to the point where they can transform the peptide, called ANK, into a suitable form for "drug cocktail" therapy. A U.S. patent application has been filed for this discovery through PARTEQ Innovations, the university's technology transfer office.
Also on the research team are Drs. Yue Zhou and Jingwen Liu (Palo Alto Health Care System); Joseph Marsh and Julie Forman-Kay (University of Toronto); and Vladimir Uversky (Indiana University). The study was partially funded by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC).

NOTE: A PDF copy of the article is available upon request.


Lorinda Peterson, Queen's News & Media Services, 613.533.3234

Attention broadcasters: Queen's has facilities to provide broadcast quality audio and video feeds. For television interviews, we can provide a live, real-time double ender from Kingston fibre optic cable. Please call for details.

Queen's University

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.